Stratos Wealth Partners’s Tema Oncology ETF CANC Stock Holding History
Bought
Maintained
Sold
Other funds holding CANC
Stratos Wealth Partners's CANC Position: Q3 2026 in Review
Stratos Wealth Partners sold out of Tema Oncology ETF (CANC) in Q3 2026, closing a stake of 19,403 shares — an estimated $800K sold.
Stratos Wealth Partners first reported a position in CANC in Q1 2026 and held it in 2 quarters. The position peaked at $800K in Q2 2026. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.
- Stratos Wealth Partners reported no remaining Tema Oncology ETF position as of Q3 2026 after selling out during the quarter.
- Stratos Wealth Partners sold 19,403 Tema Oncology ETF shares in Q3 2026, an estimated $800K.
- Stratos Wealth Partners first reported a position in Tema Oncology ETF in Q1 2026 and held it in 2 quarters.
- Stratos Wealth Partners's Tema Oncology ETF position peaked at $800K in Q2 2026.
- 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.
Based on Stratos Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.